Clinical Genomics


Clinical Genomics is the use of genome sequencing to inform patient diagnosis and care. The California Initiative to Advance Precision Medicine has just been launched, and it is being headed by UCSF’s high profile recent hire, Atul Butte.



The global market for Clinical Genomics is expected to reach USD 22.1 billion by 2020, growing at an estimated CAGR of 10.3% from 2014 to 2020, according to a new study by Grand View Research.



Genomic healthcare uses many pieces of genetic information to refine diagnoses, individualize treatments, prevent adverse drug effects, manage epidemics and develop new therapies. The incorporation of whole-genome and whole-exome sequencing into clinical practice will undoubtedly change the way genetic counselors and other clinicians approach genetic testing. Genomics play an imperative role in the field of infectious disease testing by enabling the use of fast and effective result rendering molecular diagnostic tests. Genomics based diagnostics dominated the overall market in terms of revenue at 36.4% in 2013 majorly owing to the presence of a relatively larger number of R&D programs.



 

  • Genome sequencing
  • Genomic data

Related Conference of Clinical Genomics

October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain
November 15-16, 2022

3rd Experts Meeting on Plant, Cellular and Molecular Biology

Budapest, Hungary
November 21-22, 2022

4th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada
May 03-04, 2023

16th World Congress on Stem Cell Research

Paris, France
May 03-04, 2023

Global Conference on Cell and Gene Therapy

Paris, France

Clinical Genomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in